ASB vs TFSL

ASB's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. While growth metrics are strong—evidenced by 20% YoY revenue growth and 30.4% earnings growth—the elevated P/E of 31.86 and a payout ratio exceeding 100% raise sustainability concerns. The stock trades above both the Graham Number ($23.11) and intrinsic value estimate ($24.48), implying overvaluation relative to defensive and growth-based models. Analysts concur with a 'hold' rating, and insider selling adds caution, though solid earnings beats provide some support.

TFSL exhibits significant fundamental deterioration, anchored by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect where the current price ($15.05) vastly exceeds both the Graham Number ($7.01) and Intrinsic Value ($2.24). The most critical red flag is an unsustainable dividend payout ratio of 353.13%, indicating the company is paying dividends far in excess of its earnings. This is compounded by a PEG ratio of 72.62 and stagnant earnings growth (-0.80% YoY), suggesting the stock is priced for growth that is not manifesting. Bearish insider activity from the CEO and CFO further reinforces a negative outlook.